VALERIE FONTEYNE

Mark

misc

Combinatie van een hoge dosis externe radiotherapie met een simultaan geïntegreerde boost op de dominante intraprostatische lesie : analyse van de genito-urnaire en rectale toxiciteit

Nora Sundahl (UGent) , Gert De Meerleer (UGent) , Geert Villeirs (UGent) , Piet Ost (UGent) , Wilfried De Neve (UGent) , Nicolaas Lumen (UGent) , Pieter De Visschere (UGent) , Marc Van Eijkeren (UGent) and VALERIE FONTEYNE

(2016) UROLOGIC (NEDERLANDSE EDITIE). 12(okt.). p.24-29

Mark

The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients

Annelies Van Hemelryk, Gert De Meerleer (UGent) , Piet Ost (UGent) , Filip Poelaert (UGent) , Werner De Gersem (UGent) , Karel Decaestecker (UGent) , Pieter De Visschere (UGent) and VALERIE FONTEYNE

(2016) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 96(2). p.323-332

Mark

Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity

Nora Sundahl (UGent) , Gert De Meerleer (UGent) , Geert Villeirs (UGent) , Piet Ost (UGent) , Wilfried De Neve (UGent) , Nicolaas Lumen (UGent) , Pieter De Visschere (UGent) , Marc Van Eijkeren (UGent) and VALERIE FONTEYNE

(2016) RADIOTHERAPY AND ONCOLOGY. 119(3). p.398-404

Mark

Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors

Filip Poelaert (UGent) , VALERIE FONTEYNE, Tom Claeys, Piet Ost (UGent) , Karel Decaestecker (UGent) , Gert De Meerleer (UGent) , Bert Dhondt (UGent) , Pieter De Visschere (UGent) and Nicolaas Lumen (UGent)

(2016) EUROPEAN UROLOGY SUPPLEMENTS. 15(3). p.e680-e680

Mark

What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

Pieter De Visschere (UGent) , Leslie Naesens (UGent) , Louis Libbrecht (UGent) , Charles Van Praet (UGent) , Nicolaas Lumen (UGent) , VALERIE FONTEYNE, EVA PATTYN (UGent) and Geert Villeirs (UGent)

(2016) EUROPEAN RADIOLOGY. 26(4). p.1098-1107

Mark

How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients

VALERIE FONTEYNE, Annelies Van Hemelryk, Nicolaas Lumen (UGent) , Piet Ost (UGent) , Karel Decaestecker (UGent) , Pieter De Visschere (UGent) and Gert De Meerleer (UGent)

(2015) EUROPEAN UROLOGY SUPPLEMENTS. 14(7). p.174-175

Mark

Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study

Tom Claeys, Nicolaas Lumen (UGent) , Gilles Thuysbaert, Marleen Praet (UGent) , Gert De Meerleer (UGent) , Sylvie Rottey (UGent) , Piet Ost (UGent) , Pieter De Visschere (UGent) , Geert Villeirs (UGent) , VALERIE FONTEYNE, et al.

(2015) EUROPEAN UROLOGY SUPPLEMENTS. 14(2). p.e728-e728a

Mark

journalArticle
A1
open access

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study

Filip Poelaert (UGent) , Charles Van Praet (UGent) , Anne-Sophie Beerens (UGent) , Gert De Meerleer (UGent) , VALERIE FONTEYNE, Piet Ost (UGent) and Nicolaas Lumen (UGent)

(2015) BIOMED RESEARCH INTERNATIONAL.

Mark

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire

Julie Devos (UGent) , Charles Van Praet (UGent) , Karel Decaestecker (UGent) , Tom Claeys, VALERIE FONTEYNE, Veerle Decalf (UGent) , Gert De Meerleer (UGent) , Piet Ost (UGent) and Nicolaas Lumen (UGent)

(2015) ACTA CLINICA BELGICA. 70(4). p.272-279

Mark

What kind of high-grade prostate cancers do we miss on multiparametric magentic resonance imaging?

Pieter De Visschere (UGent) , Leslie Naesens (UGent) , Louis Libbrecht (UGent) , Nicolaas Lumen (UGent) , VALERIE FONTEYNE, EVA PATTYN (UGent) and Geert Villeirs (UGent)

(2015) Electronic Presentation Online System.

Academic Bibliography

VALERIE FONTEYNE

Combinatie van een hoge dosis externe radiotherapie met een simultaan geïntegreerde boost op de dominante intraprostatische lesie : analyse van de genito-urnaire en rectale toxiciteit

The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients

Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity

Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors

What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients

Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire

What kind of high-grade prostate cancers do we miss on multiparametric magentic resonance imaging?

Contents

Support

Contact